Paper Title

THE CLINICAL STUDY OF IRON DEFICIENCY ANAEMIA [FAQR-UD-DAM BA WAJAH ZOAF-E-JIGAR] AND ITS MANAGEMENT WITH UNANI MEDICINE.

Article Identifiers

Registration ID: IJNRD_214594

Published ID: IJNRD2402334

DOI: Click Here to Get

Authors

Dr. Aaisha Khan , Dr. D Aisha Khanam , Dr. Qudsiya Aftab , Dr. Ahsan Faroqui , Dr. Lateef Siddiqui

Keywords

Iron deficiency anaemia, Soo-ul-qinya, Zoaf-e-jigar, Gul-e-Surkh [Rosa centifolia], Badiyan [Foeniculum vulgare], Parsiaoshan [Adiantum capillus-veneris], Maweez munaqqa [Vitis vinifera].

Abstract

ABSTRACT- FAQR-UD-DAM is an Arabic word which means shortage of blood. Soo-ul-qinya means alteration or deficiency in storage, attributing to iron deficiency anaemia [IDA]. Anaemia [lack of blood] is a worldwide public health issue affecting approximately 1.62 billion sufferer or approximately quarter of world population. Among anaemia IDA is most widespread and most common nutrient deficiency. It generally occurs when iron demand of the body is not met by iron absorption. IDA may be caused by deficient intake or absorption, excessive demand, repeated pregnancies or deficient utilization. Some Unani physicians have described anaemia as Zoaf-e-Jigar [weakness of liver]. They believed that alteration in the temperament of liver causes its weakness which leads to anaemia. Anaemia is the most prevalent deficiency disease and one of the major nutrition related goals globally. Unani medicine plays a vital role in the management of anaemia through its safety, efficacy and easy availability. This overview has been contemplated to highlight the beneficial aspect of Unani medicine in the management of anaemia. Aims and Objectives: To evaluate the efficacy and safety of unani formulation in the management of anaemia [Faqr-ud-Dam Ba Wajah Zoaf-e-Jigar]. Methodology: The study was conducted as single blind clinical trial to evaluate the safety and efficacy in iron deficiency anaemia [Faqr-ud-dam ba wajah zoaf-e-jigar] with polyherbal Unani formulation. The sample size of 40 patients were taken. All these patients received treatment for 90 days. Medicines [ Gul-e-Surkh, Badiyan, Parsiaoshan, were given in safoof [ powder] form 2 gm each, alongside honey [1-2 teaspoon] morning and evening daily with Maweez Munaqqa 1.5 gm before meals with proper follow-up at the interval of 15 days. The pre and post-treatment effect were then assessed based on subjective and objective parameters. Results and Conclusion: The study revealed that the drug showed great response in subjective parameters like pallor, fatigue and palpitation. The objective parameters like Hb and Serum Ferritin also showed statistically extreme significant difference [ p<0.0001]. No adverse effect or toxicity was observed during clinical trial.

How To Cite (APA)

Dr. Aaisha Khan, Dr. D Aisha Khanam, Dr. Qudsiya Aftab, Dr. Ahsan Faroqui, & Dr. Lateef Siddiqui (February-2024). THE CLINICAL STUDY OF IRON DEFICIENCY ANAEMIA [FAQR-UD-DAM BA WAJAH ZOAF-E-JIGAR] AND ITS MANAGEMENT WITH UNANI MEDICINE.. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(2), d315-d333. https://ijnrd.org/papers/IJNRD2402334.pdf

Issue

Volume 9 Issue 2, February-2024

Pages : d315-d333

Other Publication Details

Paper Reg. ID: IJNRD_214594

Published Paper Id: IJNRD2402334

Downloads: 000122012

Research Area: Medical Science

Country: Hyderabad, Telangana, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2402334.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2402334

About Publisher

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

Publication Timeline

Peer Review
Through Scholar9.com Platform

Article Preview: View Full Paper

Call For Paper

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details